Ippei Kanazawa

4.8k total citations
114 papers, 3.8k citations indexed

About

Ippei Kanazawa is a scholar working on Molecular Biology, Orthopedics and Sports Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ippei Kanazawa has authored 114 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 43 papers in Orthopedics and Sports Medicine and 32 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ippei Kanazawa's work include Bone health and osteoporosis research (39 papers), Bone Metabolism and Diseases (36 papers) and Bone health and treatments (22 papers). Ippei Kanazawa is often cited by papers focused on Bone health and osteoporosis research (39 papers), Bone Metabolism and Diseases (36 papers) and Bone health and treatments (22 papers). Ippei Kanazawa collaborates with scholars based in Japan, Canada and United States. Ippei Kanazawa's co-authors include Toshitsugu Sugimoto, Toru Yamaguchi, Mika Yamauchi, Shozo Yano, Masahiro Yamamoto, Ken-ichiro Tanaka, Soichi Kurioka, Masakazu Notsu, Ken‐ichiro Tanaka and Ayumu Takeno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Ippei Kanazawa

112 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ippei Kanazawa Japan 34 1.6k 1.5k 956 805 587 114 3.8k
Masahiro Yamamoto Japan 29 1.3k 0.8× 1.6k 1.1× 1.0k 1.1× 636 0.8× 341 0.6× 80 3.2k
Jung‐Min Koh South Korea 37 1.7k 1.0× 1.5k 1.0× 858 0.9× 998 1.2× 669 1.1× 186 4.7k
Peter Alexandersen Denmark 40 1.7k 1.0× 2.1k 1.4× 1.5k 1.5× 1.5k 1.9× 716 1.2× 83 5.4k
Sung-Kil Lim South Korea 33 994 0.6× 796 0.5× 622 0.7× 564 0.7× 577 1.0× 107 3.3k
Mika Yamauchi Japan 41 2.2k 1.3× 2.3k 1.5× 1.6k 1.6× 1.0k 1.3× 604 1.0× 126 5.6k
Moo Il Kang South Korea 25 900 0.6× 706 0.5× 517 0.5× 793 1.0× 494 0.8× 99 2.9k
Masakazu Miura Japan 30 991 0.6× 752 0.5× 551 0.6× 652 0.8× 896 1.5× 85 4.0k
Ki Won Oh South Korea 31 874 0.5× 595 0.4× 429 0.4× 682 0.8× 678 1.2× 76 2.9k
P. Vestergaard Denmark 16 796 0.5× 1.2k 0.8× 686 0.7× 503 0.6× 447 0.8× 21 2.4k
Agostino Gaudio Italy 28 810 0.5× 971 0.6× 868 0.9× 701 0.9× 219 0.4× 101 3.2k

Countries citing papers authored by Ippei Kanazawa

Since Specialization
Citations

This map shows the geographic impact of Ippei Kanazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ippei Kanazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ippei Kanazawa more than expected).

Fields of papers citing papers by Ippei Kanazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ippei Kanazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ippei Kanazawa. The network helps show where Ippei Kanazawa may publish in the future.

Co-authorship network of co-authors of Ippei Kanazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ippei Kanazawa. A scholar is included among the top collaborators of Ippei Kanazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ippei Kanazawa. Ippei Kanazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanazawa, Ippei, et al.. (2019). A scoring assessment tool for the risk of vertebral fractures in patients with type 2 diabetes mellitus. Bone. 122. 38–44. 6 indexed citations
2.
Takeno, Ayumu, Ippei Kanazawa, Ken‐ichiro Tanaka, Masakazu Notsu, & Toshitsugu Sugimoto. (2019). Phloretin Suppresses Bone Morphogenetic Protein-2-Induced Osteoblastogenesis and Mineralization via Inhibition of Phosphatidylinositol 3-kinases/Akt Pathway. International Journal of Molecular Sciences. 20(10). 2481–2481. 19 indexed citations
3.
Tanaka, Ken-ichiro, Yingben Xue, Loan Nguyen‐Yamamoto, et al.. (2018). FAM210A is a novel determinant of bone and muscle structure and strength. Proceedings of the National Academy of Sciences. 115(16). E3759–E3768. 35 indexed citations
4.
Takeno, Ayumu, Ippei Kanazawa, Masakazu Notsu, Ken‐ichiro Tanaka, & Toshitsugu Sugimoto. (2018). Phloretin Promotes Adipogenesis via Mitogen-Activated Protein Kinase Pathways in Mouse Marrow Stromal ST2 Cells. International Journal of Molecular Sciences. 19(6). 1772–1772. 21 indexed citations
5.
Kanazawa, Ippei, Sayuri Tanaka, & Toshitsugu Sugimoto. (2018). The Association Between Osteocalcin and Chronic Inflammation in Patients with Type 2 Diabetes Mellitus. Calcified Tissue International. 103(6). 599–605. 13 indexed citations
6.
Kanazawa, Ippei & Toshitsugu Sugimoto. (2016). [Diabetes mellitus and bone].. PubMed. 26(8). 1185–93. 1 indexed citations
7.
Miyazaki, Yusei, Masaaki Niino, Ippei Kanazawa, et al.. (2016). Fingolimod suppresses bone resorption in female patients with multiple sclerosis. Journal of Neuroimmunology. 298. 24–31. 9 indexed citations
8.
9.
Tanaka, Ken-ichiro, Toru Yamaguchi, Ippei Kanazawa, & Toshitsugu Sugimoto. (2015). Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells. Biochemical and Biophysical Research Communications. 461(2). 193–199. 144 indexed citations
10.
Tanaka, Ken-ichiro, Hiroshi Kaji, Toru Yamaguchi, et al.. (2013). Involvement of the Osteoinductive Factors, Tmem119 and BMP-2, and the ER Stress Response PERK–eIF2α–ATF4 Pathway in the Commitment of Myoblastic into Osteoblastic Cells. Calcified Tissue International. 94(4). 454–464. 48 indexed citations
11.
Kanazawa, Ippei, Ken-ichiro Tanaka, N. Ogawa, et al.. (2012). Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus. Osteoporosis International. 24(3). 1115–1119. 45 indexed citations
12.
Canaff, Lucie, et al.. (2011). Menin Missense Mutants Encoded by the MEN1 Gene that Are Targeted to the Proteasome: Restoration of Expression and Activity by CHIP siRNA. The Journal of Clinical Endocrinology & Metabolism. 97(2). E282–E291. 39 indexed citations
13.
Kurioka, Soichi, Toru Yamaguchi, Miwa Morita, et al.. (2011). Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes. Diabetes Research and Clinical Practice. 94(2). 180–185. 69 indexed citations
14.
Kanazawa, Ippei, Mika Yamamoto, T. Yamaguchi, & Toshitsugu Sugimoto. (2011). Effects of Metformin and Pioglitazone on Serum Pentosidine Levels in Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 119(6). 362–365. 35 indexed citations
15.
Kanazawa, Ippei, Toru Yamaguchi, Mika Yamauchi, et al.. (2010). Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporosis International. 22(1). 187–194. 215 indexed citations
16.
Kanazawa, Ippei, et al.. (2010). Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmenopausal Women With Type 2 Diabetes Mellitus Accompanied With Osteoporosis. The American Journal of the Medical Sciences. 339(6). 519–524. 21 indexed citations
17.
Kanazawa, Ippei, Toru Yamaguchi, Shozo Yano, et al.. (2010). Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus. Osteoporosis International. 21(12). 2013–2018. 31 indexed citations
18.
Kanazawa, Ippei. (2009). [Usefulness of metformin in diabetes-related bone disease].. PubMed. 19(9). 1319–25. 6 indexed citations
19.
Kanazawa, Ippei, Toru Yamaguchi, Shozo Yano, et al.. (2007). Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biology. 8(1). 51–51. 156 indexed citations
20.
Yano, Sachiko, Tomohiro Yamaguchi, Ippei Kanazawa, et al.. (2007). The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure. Nephrology Dialysis Transplantation. 22(11). 3160–3165. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Yamamoto Breakdown of academic impact, for papers by Jung‐Min Koh Breakdown of academic impact, for papers by Peter Alexandersen Breakdown of academic impact, for papers by Sung-Kil Lim Breakdown of academic impact, for papers by Mika Yamauchi Breakdown of academic impact, for papers by Moo Il Kang Breakdown of academic impact, for papers by Masakazu Miura Breakdown of academic impact, for papers by Ki Won Oh Breakdown of academic impact, for papers by P. Vestergaard Breakdown of academic impact, for papers by Agostino Gaudio
Rankless by CCL
2026